The Belt and Road: Cooperation, Harmony and Win-Win
products

Nutraceutical

  • Simvastatin  CAS:79902-63-9 Manufacturer Supplier

    Simvastatin CAS:79902-63-9 Manufacturer Supplier

    Simvastatin is an once-daily hypolipemic, an analog of lovastatin indicated for the treatment of atherosclerosis. In patients with Type IN or IIB hypercholesterolemia, simvastatin reportedly produces significant reductions in total serum cholesterol, LDL, mglycerides and apolipoprotein-B, while HDL and apolipoprotein-A levels are increased.

  • Arginine HCL  CAS:1119-34-2 Manufacturer Supplier

    Arginine HCL CAS:1119-34-2 Manufacturer Supplier

    Arginine HCL is a salt form of L-Arginine, where hydrochloric acid is added to enhance stability and solubility. Arginine hydrochloride is a L-alpha-amino acid. An essential amino acid that is physiologically active in the L-form. L-Arginine might be effective at lowering blood pressure, reducing the symptoms of angina and PAD , and treating erectile dysfunction due to a physical cause.

  • L-Carnitine Fumarate  CAS:90471-79-7 Manufacturer Supplier

    L-Carnitine Fumarate CAS:90471-79-7 Manufacturer Supplier

    L-Carnitine fumarate is a stable form of L-carnitine, easy to absorb moisture as a white powder or crystalline powder,soluble in water.Fumarate is a salt and fumaric acid esters, is in the body and certain types of naturally occurring within moss and mushrooms. It is widely used as a food additive.

  • Diosmin  CAS:520-27-4  Manufacturer Supplier

    Diosmin CAS:520-27-4 Manufacturer Supplier

    Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a glycosyloxyflavone, a rutinoside, a disaccharide derivative, a monomethoxyflavone and a dihydroxyflavanone. It derives from a diosmetin.

  • Liraglutide  CAS:204656-20-2 Manufacturer Supplier

    Liraglutide CAS:204656-20-2 Manufacturer Supplier

    Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.

  • Trilostane  CAS:13647-35-3 Manufacturer Supplier

    Trilostane CAS:13647-35-3 Manufacturer Supplier

    Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing’s syndrome and primary hyperaldosteronism. These are both disorders where excess amounts of corticosteroid hormones are produced in the body. Corticosteroids are essential for the body to make use of carbohydrates, fats and proteins and for a normal response to stress.

  • Carbocysteine(S-CMC)  CAS:638-23-3 Manufacturer Supplier

    Carbocysteine(S-CMC) CAS:638-23-3 Manufacturer Supplier

    Carbocysteine is prescribed for conditions characterized by the accumulation of excessive mucus. Although often described as a mucolytic, its function is probably that of mucoregulation, which results in physical changes in accumulated secretions that are favorable in terms of clearance. The chemistry, pharmacology, pharmacokinetics, clinical applications, and toxicology of carbocysteine are reviewed.

  • D,L-Alpha-Hydroxymethionine Calcium CAS:4857-44-7

    D,L-Alpha-Hydroxymethionine Calcium CAS:4857-44-7

    D,L-Alpha-Hydroxymethionine Calcium is mainly used to Prevent and treat the protein metabolism disorders caused by chronic renal insufficiency.Calcium hydroxymethionine is mainly used as a feed additive. MHA has been used in animal husbandry since the 1950s, and MHA has proven to be a superior source of methionine for feed, livestock and pet manufacturers.

  • Pioglitazone HCL  CAS:112529-15-4 Manufacturer Supplier

    Pioglitazone HCL CAS:112529-15-4 Manufacturer Supplier

    Pioglitazone hydrochloride is an oral antidiabetic agent used in the treatment of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes.Pioglitazone is reported to be safe and well tolerated and is said to have a lower occurrence of hepatic toxicity as well as a low probability for drug interaction.

  • N-Acetyl-L-Arginine  CAS:155-84-0 Manufacturer Supplier

    N-Acetyl-L-Arginine CAS:155-84-0 Manufacturer Supplier

    N-Acetyl-L-Arginine is a non-essential amino acid for adults, but it is produced slowly in the body. It is an essential amino acid for infants and young children, and has a certain detoxification effect. It exists in a large amount in protamine, etc., and is also the basic composition of various proteins, and it exists very widely. Under normal circumstances, the body itself can produce enough L-arginine.

  • Flutamide  CAS:13311-84-7  Manufacturer Supplier

    Flutamide CAS:13311-84-7 Manufacturer Supplier

    Flutamide is a monocarboxylic acid amide and a member of (trifluoromethyl)benzenes. It has a role as an androgen antagonist and an antineoplastic agent.Flutamide is a kind of synthetic, non-steroidal antiandrogen which is mainly used for the treatment of prostate cancer. It is a kind of toluidine derivative and a nonsteroidal antiandrogen with a similar structure of bicalutamide and nilutamide.

  • Setmelanotide  CAS:920014-72-8 Manufacturer Supplier

    Setmelanotide CAS:920014-72-8 Manufacturer Supplier

    Setmelanotide is a melanocortin 4 receptor (MC4R) agonist, which acts on human and rat MC4R; The mechanism of MC4R activation by setmelanotide may be different from that of natural ligands and the first generation synthetic agonists; Set melanotide may play a role by antagonizing the neurotransmitters that naturally exist and inhibit the activation of MC4R; It has been confirmed that Setmelanotide has a positive effect in the treatment of obesity and has reached the clinical end point of phase 3.